Recursion Pharmaceuticals Inc Clas (RXRX)
EBITDA
-$444.45M
TTM · Period ending: · USD
RXRX EBITDA
Latest reported-$444.45Mperiod ending
Latest reported-$444.45Mperiod ending
RXRX EBITDA (-$59.39M → -$444.45M)
Annual EBITDA
High-resolution chart · PNG
RXRX ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -559,384,000 | |
| -426,722,000 | |
| -307,629,000 | |
| -227,665,000 | |
| -175,122,000 | |
| -81,703,000 | |
| -59,390,000 |